{"id":7307,"date":"2020-06-03T13:09:00","date_gmt":"2020-06-03T20:09:00","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=7307"},"modified":"2021-03-24T13:09:45","modified_gmt":"2021-03-24T20:09:45","slug":"rapid-point-of-care-nucleic-acid-testing-for-sars-cov-2-in-hospitalised-patients-a-clinical-trial-and-implementation-study","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/06\/03\/rapid-point-of-care-nucleic-acid-testing-for-sars-cov-2-in-hospitalised-patients-a-clinical-trial-and-implementation-study\/","title":{"rendered":"Rapid Point of Care Nucleic Acid Testing for SARS-CoV-2 in\u00a0Hospitalised\u00a0Patients\u00a0a Clinical Trial and Implementation Study"},"content":{"rendered":"<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"34\" data-aria-posinset=\"1\" data-aria-level=\"1\"><i><span data-contrast=\"none\">[pre-print, not peer reviewed]<\/span><\/i><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">Collier et al. evaluated a point of care (POC) nucleic acid amplification test (NAAT) (called the SAMBA II) for SARS-CoV-2. The sensitivity and specificity of SAMBA II were 96.9% and 99.1%, respectively, and the median time to test result was 2.6 hours. The authors also compared hospital outcomes associated with implementation of POC testing within a large teaching hospital, compared to the standard RT-PCR tests for SARS-<\/span><span data-contrast=\"auto\">Co<\/span><span data-contrast=\"auto\">V<\/span><span data-contrast=\"auto\">-2. Implementation of the SAMBA II POC tests was associated with faster time to triage from the ED, release of isolation rooms, and avoidance of hospital bay closures.<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><i><span data-contrast=\"none\">Collier et al. (June 2, 2020). Rapid Point of Care Nucleic Acid Testing for SARS-CoV-2 in\u00a0Hospitalised\u00a0Patients\u00a0a Clinical Trial and Implementation Study.\u00a0Preprint\u00a0downloaded\u00a0June\u00a03 from\u00a0<\/span><\/i><a href=\"https:\/\/doi.org\/10.1101\/2020.05.31.20114520\"><span data-contrast=\"none\">https:\/\/doi.org\/10.1101\/2020.05.31.20114520<\/span><\/a><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559685&quot;:720,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[pre-print, not peer reviewed]\u00a0Collier et al. evaluated a point of care (POC) nucleic acid amplification test (NAAT) (called the SAMBA II) for SARS-CoV-2. The sensitivity and specificity of SAMBA II were 96.9% and 99.1%, respectively, and the median time to test result was 2.6 hours. The authors also compared hospital outcomes associated with implementation of&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/06\/03\/rapid-point-of-care-nucleic-acid-testing-for-sars-cov-2-in-hospitalised-patients-a-clinical-trial-and-implementation-study\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[],"topic":[19],"class_list":["post-7307","post","type-post","status-publish","format-standard","hentry","category-article-summary","topic-testing-and-treatment"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/7307","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=7307"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/7307\/revisions"}],"predecessor-version":[{"id":7308,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/7307\/revisions\/7308"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=7307"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=7307"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=7307"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=7307"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}